This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page ADP4-ADP4, February 1, 2025. Introduction:Intravenous thrombolysis with alteplase (tPA) or tenecteplase (TNK) is a first-line treatment for acute ischemic stroke. The most serious risk associated with IV thrombolytics is symptomatic intracranial hemorrhage (sICH).
Stroke, Volume 55, Issue Suppl_1 , Page AWP202-AWP202, February 1, 2024. Background:Mechanical thrombectomy (MT) has demonstrated superiority over medical therapy for acute ischemic stroke (AIS) with large vessel occlusion (LVO). Propensity score matching was performed to create two well-balanced groups: MT alone and MT+IVtPA.
Stroke, Volume 56, Issue Suppl_1 , Page ATP87-ATP87, February 1, 2025. Background:Early prediction of functional outcome after rtPA helps clinicians in prognostic conversations with stroke patients and their families. Data on demographics, clinical presentations, laboratory values, neuroimaging, and stroke metrics were collected.
Stroke, Volume 55, Issue Suppl_1 , Page ATP82-ATP82, February 1, 2024. Introduction:The incidence of Large Vessel Occlusion-Acute Ischemic Stroke (LVO-AIS) continues to increase in young adults. 31 patients (18%) had stroke etiology as Large Artery Atherosclerosis (per TOAST criteria). received IV thrombolysis and 43.9%
Stroke, Volume 56, Issue Suppl_1 , Page AWP246-AWP246, February 1, 2025. Introduction:Acute ischemic stroke (AIS) arising from Medium vessel occlusions (MeVO) poses substantial challenges in treatment and management. Cardioembolic stroke etiology was associated with a higher likelihood of excellent recanalization (1.67; 95% CI, 1.07-2.59;
Stroke, Volume 56, Issue Suppl_1 , Page AWP83-AWP83, February 1, 2025. Background:Stroke centers across the country followadhere to established best practice timeframes for stroke care delivery, such as door-to-doctor, door-to-CT, and door-to-needle times. 45 mins), on-scene-to-evaluation time improved by 48% (1.54
Stroke, Volume 55, Issue Suppl_1 , Page ATMP86-ATMP86, February 1, 2024. Introduction:Tenecteplase improves reperfusion and functional outcomes in stroke patients with large vessel occlusion. A t-test was used to examine association between outcomes and thrombolysis type. Median NIHSS at presentation (18.0 versus 16.0,
Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. Background:Patients with acute ischemic stroke harboring a large vessel occlusion (LVO) admitted to non endovascular-capable centers often require inter-hospital transfer for thrombectomy.
Stroke, Volume 55, Issue Suppl_1 , Page ATP195-ATP195, February 1, 2024. This study compares post-thrombectomy outcomes in both groups, matched by initial NIHSS scores.Method:From October 2017 to March 2023, we studied LVO cases undergoing thrombectomy for acute ischemic stroke. However, clinical outcomes remain similar.
Stroke, Volume 56, Issue Suppl_1 , Page AWP189-AWP189, February 1, 2025. Here, we assess the performance characteristics of non-contrast head CT versus CT perfusion at predicting final infarct volume (FIV) in patients with large core acute ischemic stroke (AIS) undergoing endovascular therapy (EVT).Methods:From IQR, 0-29].
Discovering discrepancies in a major published trial from the pharma-academic complex would be a boost to those seeking to force trial data to be public, and that is exactly what a group of investigators attempted to do with a major cholesterol lowering trial published in 2017. But first, some background. Cholesterol lowering is big business.
Stroke, Volume 54, Issue 12 , Page 3002-3011, December 1, 2023. BACKGROUND:There is limited information on the delivery of acute stroke therapies and secondary preventive measures and clinical outcomes over time in young adults with acute ischemic stroke. in 2017–2019) and 3-month modified Rankin Scale scores 0 to 1 (68.3%–69.1%)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content